Materion (MTRN) Q4 2025 earnings summary

Executive summary

• Fourth quarter and full-year 2025 results were strong, with significant improvements in profitability and margin expansion, led by Electronic Materials and Precision Optics; organic growth was 7% year-over-year excluding the quality event.

• Electronic Materials had its strongest sales quarter in nearly three years, driven by semiconductor market growth and AI demand, with 8% organic value-added sales growth and ~300 bps margin expansion year-over-year.

• Precision Optics delivered a 26% sales increase in Q4 and ~800 bps margin expansion year-over-year.

• Performance Materials was affected by the quality event but maintained strong margins and improved profitability due to cost actions.

• Backlog increased 7% year-over-year, with a 12% improvement in the second half versus the first half.

Financial highlights

• Q4 2025 value-added sales were $253.9 million, up 7% organically excluding precision clad strip; all-in VAS down 14% due to the quality event.

• Q4 adjusted EBITDA was $57.0 million (22.5% of VAS), up 170 basis points in margin year-over-year.

• Q4 adjusted EPS was $1.53, up 9% sequentially; full-year adjusted EPS was $5.44, up 2% year-over-year.

• Full-year VAS was $1.05 billion, up 4% organically excluding precision clad strip; adjusted EBITDA was $217 million (20.7% of VAS), slightly down from $221.2 million (20.2%).

• Q4 net income was $6.6 million ($0.31/share) vs. a net loss of $48.8 million prior year; full-year net income was $74.8 million ($3.58/share) vs. $5.9 million prior year.

Outlook and guidance

• 2026 adjusted EPS guidance is $6.00–$6.50, a 15% increase at midpoint over 2025, with mid-single-digit+ sales growth and continued margin expansion toward a 23% EBITDA margin target.

• Free cash flow performance expected to improve with higher cash earnings and better working capital management.

• Q1 2026 will be seasonally slower with additional costs from ramping clad strip production, but earnings expected to be about 10% higher than Q1 2025.

• Capital expenditures planned at $75 million, with a balanced approach to capital allocation.